|
OSGIN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.020500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.774200E-02 |
| Normal-vs-Stage2 |
1.327850E-01 |
| Normal-vs-Stage3 |
7.655000E-03 |
| Normal-vs-Stage4 |
1.909040E-01 |
| Stage1-vs-Stage2 |
7.506400E-01 |
| Stage1-vs-Stage3 |
3.713900E-02 |
| Stage1-vs-Stage4 |
3.418200E-01 |
| Stage2-vs-Stage3 |
1.739990E-01 |
| Stage2-vs-Stage4 |
4.260800E-01 |
| Stage3-vs-Stage4 |
8.976400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.375900E-03 |
| Normal-vs-AfricanAmerican |
1.451210E-01 |
| Normal-vs-Asian |
3.441200E-01 |
| Caucasian-vs-AfricanAmerican |
5.708200E-01 |
| Caucasian-vs-Asian |
5.082000E-01 |
| AfricanAmerican-vs-Asian |
4.554400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.458300E-02 |
| Normal-vs-Female |
1.783640E-03 |
| Male-vs-Female |
4.164200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.407600E-01 |
| Normal-vs-Extreme_Weight |
2.537000E-01 |
| Normal-vs-Obese |
2.955800E-03 |
| Normal-vs-Extreme_Obese |
5.055600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.918000E-01 |
| Normal_Weight-vs-Obese |
1.271570E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.582400E-01 |
| Extreme_Weight-vs-Obese |
4.048200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.216200E-01 |
| Obese-vs-Extreme_Obese |
3.680000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.862200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.902000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.873380E-01 |
| Normal-vs-Age(81-100Yrs) |
5.197400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.119810E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.597600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.624000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.634580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.823200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.516800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.695700E-02 |
| Normal-VS-Type2 PRCC |
3.159800E-02 |
| Normal-VS-KIRP CIMP |
1.112210E-02 |
| Normal-VS-Unclassified PRCC |
2.838400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.024200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.797630E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.269200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.335880E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.884000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.632200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.904800E-01 |
| Normal-vs-N1 |
1.143730E-03 |
| Normal-vs-N2 |
1.490420E-01 |
| N0-vs-N1 |
1.284830E-03 |
| N0-vs-N2 |
1.370170E-01 |
| N1-vs-N2 |
8.265600E-01 |
|
|
